1. Home
  2. ROIV vs ALB Comparison

ROIV vs ALB Comparison

Compare ROIV & ALB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$27.08

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

ALB

Albemarle Corporation

HOLD

Current Price

$186.12

Market Cap

18.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
ALB
Founded
2014
1994
Country
United Kingdom
United States
Employees
N/A
7800
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
20.7B
18.5B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
ROIV
ALB
Price
$27.08
$186.12
Analyst Decision
Strong Buy
Buy
Analyst Count
9
20
Target Price
$28.94
$178.21
AVG Volume (30 Days)
4.5M
1.8M
Earning Date
05-28-2026
05-06-2026
Dividend Yield
N/A
0.84%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$29,053,000.00
N/A
Revenue This Year
N/A
$12.12
Revenue Next Year
$744.61
$5.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.58
$53.70
52 Week High
$30.33
$215.71

Technical Indicators

Market Signals
Indicator
ROIV
ALB
Relative Strength Index (RSI) 43.41 52.24
Support Level $26.94 $156.95
Resistance Level $27.94 $188.48
Average True Range (ATR) 0.85 9.61
MACD -0.12 0.25
Stochastic Oscillator 14.42 36.65

Price Performance

Historical Comparison
ROIV
ALB

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About ALB Albemarle Corporation

Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.

Share on Social Networks: